Tessa Cigler, M.D., M.P.H.


Journal Articles

Cigler, T. and L. Vahdat. Integrating epothilones into the treatment of patients with metastatic breast cancer: clinical perspectives on incorporating recent data in the practice setting. Clin Breast Cancer, 2008. 8 Suppl 4: p. S166-70.

Cigler, T. and P.E. Goss. Breast cancer adjuvant endocrine therapy. Cancer J, 2007. 13(3): p. 148-55.

Cigler, T. and P.E. Goss. Aromatase inhibitor withdrawal response in metastatic breast cancer. J Clin Oncol, 2006. 24(12): p. 1955-6.

Kauff, N.D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D., Wadsworth, E., Lee, J., Cigler, T., Borgen, P. I., Norton, L., Barakat, R. R., Offit, K. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. J Natl Cancer Inst, 2005. 97(18): p. 1382-4.

Cigler, T., LaForge, K. S., McHugh, P. F., Kapadia, S. U., Leal, S. M., Kreek, M. J. Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence. Am J Med Genet, 2001. 105(6): p. 489-97.


Book Chapters


Cigler, T, Ryan PD. Breast Cancer Genetics and Clinical Presentation. Harrison’s Handbook of Oncology, Bruce Chabner, Thomas Lynch, Dan Longo eds. 2007 McGraw-Hill, New York, NY.



Back to topBack To Top